Qube Research & Technologies Ltd

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1729829 LONDON, X0

Position in ADPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,874,552

-$5,971,406 QoQ

Shares Held

639,377

-30.1% QoQ

Ownership

0.399%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $924,641,036 across 18 Diagnostics & Research names. ADPT ranks #10 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	A	Agilent Technologies, Inc.	2,280,319	$259,910,759
2	DHR	Danaher Corp /De/	1,348,956	$255,762,057
3	DGX	Quest Diagnostics Inc	734,714	$143,989,249
4	TMO	Thermo Fisher Scientific Inc.	188,774	$92,788,084
5	NTRA	Natera, Inc.	306,300	$61,256,937
6	IDXX	Idexx Laboratories Inc /De	85,650	$48,125,878
7	CSTL	Castle Biosciences Inc	559,583	$13,737,762
8	QGEN	Qiagen N.V.	313,960	$12,570,958

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,874,552	639,377	-30.1%	Shares	Sole	2026-05-15
2025-12-31	$14,845,958	914,160	-4.0%	Shares	Sole	2026-02-17
2025-09-30	$14,245,345	952,229	+161.1%	Shares	Sole	2025-11-14
2025-06-30	$4,249,547	364,768	+623.1%	Shares	Sole	2025-08-14
2023-12-31	$247,195	50,448	-16.7%	Shares	Sole	2024-02-13
2023-09-30	$330,084	60,566	+46.8%	Shares	Sole	2023-11-13
2023-06-30	$276,794	41,251	-35.3%	Shares	Sole	2023-08-14
2023-03-31	$562,877	63,746	-26.1%	Shares	Sole	2023-05-15
2022-09-30	$614,313	86,280	+36.2%	Shares	Sole	2022-11-14
2022-06-30	$512,420	63,340	+18.0%	Shares	Sole	2022-08-15
2022-03-31	$744,953	53,671	+146.5%	Shares	Sole	2022-05-09
2021-03-31	$876,742	21,777	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.